Ambarella, Inc. AMBA · NASDAQ
$61.70 -2.60% (-$1.65)
Summary
31 / 100 · Bulios Score
What speaks for it
- It holds more cash than debt: $101.9M against $12.6M.
- Analysts expect revenue to grow by 37% this fiscal year.
What to watch
- The company made a loss over the last 12 months.
- The share price is above the Bulios Fair Price.
- Revenue fell by 5.0% a year over the last 3 years.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
The company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 4.5% a year over 5 years. Over the last 3 years it fell by 5.0% a year. For the next fiscal year analysts expect revenue to grow by 37%.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of $56.3M.
Profitability in detailIs it financially healthy?
YesIt could repay all its debt from a single year of free cash flow. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 21
- Hold 14
- Sell 1
Today's price within the analysts' price targets
The average target of $85.5 is 39% above today's price. 58% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2026By product
The company reports no revenue by product.
By region
- TAIWAN 85%
- North America Other Than United States 6.8%
- Europe 6.3%
- UNITED STATES 1.8%
TAIWAN brings in 85% of revenue.
Segments in detail